Literature DB >> 6168629

An active intermediate formed in the reaction of bleomycin-Fe(II) complex with oxygen.

H Kuramochi, K Takahashi, T Takita, H Umezawa.   

Abstract

The base-release activity of oxygen adduct of bleomycin-Fe(II) complex [BLM-Fe(II)] from DNA decreased with a half-life of 5.2 minutes, when incubated at 0 degrees C in 0.05 M Tris-HCl buffer at pH 7.8 in the absence of DNA. Under the same condition, however, visible and ESR spectra showed that the adduct was immediately converted into the ferric complex. The ESR study further indicated the simultaneous formation of two kinds of the low-spin BLM-Fe(III) complex. One of them disappeared in parallel with the decrease of the base-release activity and transformed into the other. The latter Fe(III) complex was stable but inactive. However, by addition of hydrogen peroxide to the latter, the former was regenerated and the base-release activity appeared. Oxygen concentration measurements by oxygraph showed that one mole of BLM-Fe(II) consumed approximately 0.5 mole of molecular oxygen instantly, but did not any more thereafter in the absence of a reducing agent. While in the presence of 2-mercaptoethanol, the oxygen consumption proceeded biphasically, and equimolar oxygen was consumed by BLM-Fe(II) in the first rapid reaction. These results suggest that oxygen adduct of BLM-Fe(II) is reduced by one electron transfer from an external electron donor and the resulting BLM-Fe(III)-O2H- [or its deprotonated form: BLM-Fe(III)-O2(2)-] shows the activity to break DNA accompanying the base-release.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168629     DOI: 10.7164/antibiotics.34.576

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

1.  Identification of oligonucleotide fragments produced in a strand scission reaction of the d(C-G-C-G-C-G) duplex by bleomycin.

Authors:  S Uesugi; T Shida; M Ikehara; Y Kobayashi; Y Kyogoku
Journal:  Nucleic Acids Res       Date:  1984-02-10       Impact factor: 16.971

2.  Characterization of bleomycin-mediated cleavage of a hairpin DNA library.

Authors:  Zachary J Segerman; Basab Roy; Sidney M Hecht
Journal:  Biochemistry       Date:  2013-07-22       Impact factor: 3.162

3.  Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methods.

Authors:  Lei V Liu; Caleb B Bell; Shaun D Wong; Samuel A Wilson; Yeonju Kwak; Marina S Chow; Jiyong Zhao; Keith O Hodgson; Britt Hedman; Edward I Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

4.  Oxidative cell wall damage mediated by bleomycin-Fe(II) in Saccharomyces cerevisiae.

Authors:  S T Lim; C K Jue; C W Moore; P N Lipke
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

5.  Further insights into the mechanism of the reaction of activated bleomycin with DNA.

Authors:  Marina S Chow; Lei V Liu; Edward I Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

6.  Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin.

Authors:  T Yamauchi; T A Raffin; P Yang; B I Sikic
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.